A study published in the July 30 issue of the journal Lancet has confirmed findings by others that neither Zoloft or Remeron (and by extension, other “anti”depressants) have any benefit for treating depression in dementia patients, points out that these chemicals have numerous and common adverse effects, and recommends these chemicals should not be given to cognitively-impaired elderly.
“Because of the absence of benefit compared with placebo and increased risk of adverse events, the present practice of use of these antidepressants, ...
Continue Reading →SEP
